[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100166536":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":26,"responsibleParty":47,"collaborators":10,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":10,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":69,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":10,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"National Institutes of Health Clinical Center (CC)","NIH",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"1\u002F Patients with cancer, other tumors, or possible genetic tumor",null,"Patients enrolled on IRB approved NIH Intramural Research Program (IRP) therapeutic clinical trials",[13],{"name":14,"affiliation":15,"role":16},"William D Figg, Pharm.D.","National Cancer Institute (NCI)","PRINCIPAL_INVESTIGATOR",[18,23],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Deneise C Francis, R.N.","CONTACT","(240) 858-3974","deneise.francis@nih.gov",{"name":14,"role":20,"phone":24,"phoneExt":10,"email":25},"(240) 760-6179","figgw@mail.nih.gov",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"National Institutes of Health Clinical Center","RECRUITING","Bethesda","Maryland","20892","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-77.10026,38.98067,{"lat":39,"lon":38},[42],{"name":43,"role":20,"phone":44,"phoneExt":45,"email":46},"For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)","800-411-1222","TTY dial 711","ccopr@nih.gov",{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100166536","collection-of-blood-from-patients-with-cancer-other-tumors-or-tumor-predisposition-syndromes-for-genetic-analysis-100166536",false,"NCT01441089","Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis","Collection of Blood From Therapeutic Trial Participants for Analysis of Genetic Differences in Drug Disposition and Pharmacokinetics of Probe Medications","* INCLUSION CRITERIA:\n* Any individual currently enrolled in an NIH intramural research program clinical trials receiving treatment.\n* Ability of participant or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document.\n* Age \\>= 3 years old\n\nEXCLUSION CRITERIA:\n\n-N\u002FA","ALL","3 Years",{"count":59,"type":60},1100,"ESTIMATED","OBSERVATIONAL","Background:\n\n\\- Some genes may be associated with a greater chance of side effects during cancer treatment. These genes may also make certain treatments less effective. Researchers want to collect blood or cheek swab samples from people having cancer treatment to study these genes.\n\nObjectives:\n\n\\- To obtain a blood or cheek swab sample to study genetic differences that may affect cancer treatment.\n\nEligibility:\n\n\\- Individuals with cancer who are being treated at the National Cancer Institute.\n\nDesign:\n\n* Participants will provide a blood sample for study.\n* Participants who have blood-based cancer, such as leukemia, will provide a cheek swab sample.\n* If the blood or cheek swab sample does not have enough genetic material for analysis, an additional sample may be collected.",[64,65,66,67,68],"Prostate Cancer","Breast Cancer","Lung Cancer","Ovarian Cancer","Lymphoma",[70,71,72,73,74,75,76],"Pharmacogenetics","Pharmacokinetics","Pharmacodynamics","Clinical Outcome","Drug Metabolism and Transport","Natural History","Cancer","2026-08-15",{"date":79,"type":80},"2026-08-18","ACTUAL",{"date":82,"type":80},"2012-05-21",{"name":15,"class":6},1]